UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

(Amendment No. 2)*

Under the Securities Exchange Act of 1934

ALBANY MOLECULAR RESEARCH, INC.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

012423109

(CUSIP Number)

December 31, 2017

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP NO. 012423109
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons (entities only):
	Permian Investment Partners, LP
(2) Check the Appropriate Box if a Member of a Group			(a) [ ]
			(b) [ ]

(3) SEC Use Only
(4) Citizenship or Place of Organization
	Delaware, United States
Number of Shares Beneficially Owned By Each Reporting Person With
		(5) Sole Voting Power:	0*
		(6) Shared Voting Power:	0*
		(7) Sole Dispositive Power:	0*
		(8) Shared Dispositive Power:	0*

(9) Aggregate Amount Beneficially Owned by Each Reporting Person
	0*
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions): N/A
(11) Percent of Class Represented by Amount in Row (9): 0.0%*
(12) Type of Reporting Person (See Instructions): IA

* As of December 31, 2017, Permian Master Fund, LP and accounts (collectively, the “Fund and Accounts”) which are managed by Permian Investment Partners, LP (“Permian”) hold 0 shares of common stock, $0.01 par value per share (the “Shares”), of Albany Molecular Research, Inc., a Delaware corporation (the “Company”).

Item 1(a). Name Of Issuer:
	Albany Molecular Research, Inc.
Item 1(b). Address of Issuer’s Principal Executive Offices:
	26 Corporate Circle, Albany, New York 12212
Item 2(a). Name of Person Filing:
	Permian Investment Partners, LP
Item 2(b). Address of Principal Business Office or, if None, Residence:
	295 Madison Avenue, New York, NY 10017
Item 2(c). Citizenship:
	Delaware, United States
Item 2(d). Title of Class of Securities:
	Common Stock, par value $0.01 per share
Item 2(e). CUSIP No.:
	012423109
Item 3. If This Statement Is Filed Pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
	Not Applicable.
Item 4. Ownership:
		(a) Amount beneficially owned:	0*
		(b) Percent of class:	0.0%^*

(c) Number of shares as to which such person has:
	(i) Sole power to vote or to direct the vote:	0*
	(ii) Shared power to vote or to direct the vote:	0^*
	(iii) Sole power to dispose or to direct the disposition of:	0*
	(iv) Shared power to dispose or to direct the disposition of:	0^*

__________________

Item 5. Ownership of Five Percent or Less of a Class.
	If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ X ].
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
	Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
	Not Applicable.
Item 8. Identification and Classification of Members of the Group.
	Not Applicable.
Item 9. Notice of Dissolution of Group.
	Not Applicable.

Item 10. Certification.
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	February 14, 2018

	PERMIAN INVESTMENT PARTNERS, LP

	By: HTC Partners, LLC


	By:	/s/ Joseph Swain
		Name: Joseph Swain
		Title: Authorized Person

Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).

ALBANY MOLECULAR RESEARCH INC SC 13G/A